In both men and women, the NAFLD group had a higher ALT, AST, TC, TG, LDL, GGT, FBG, SBP, and DBP than the non-NAFLD (p < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.